India to Sri Lanka: Actinomycin Export Trade Route
India has recorded 6 verified shipments of Actinomycin exported to Sri Lanka, representing a combined trade value of $24.5K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $4.1K USD. The leading Indian exporter is GETWELL PHARMA INDIA PRIVATE LIMITED, which accounts for 52% of total export value with 4 shipments worth $12.8K USD. On the buying side, BANK OF CEYLON is the largest importer in Sri Lanka with $11.7K USD in purchases. The top 3 suppliers — GETWELL PHARMA INDIA PRIVATE LIMITED, UNITED BIOTECH PRIVATE LIMITED, AMBICA PHARMA — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Sri Lanka Actinomycin corridor is one of India's established pharmaceutical export routes, with 6 shipments documented worth a combined $24.5K USD. The route is dominated by GETWELL PHARMA INDIA PRIVATE LIMITED, which alone accounts for roughly 52% of all export value, reflecting the consolidated nature of India's actinomycin manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $4.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with actinomycin's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 34.0%, placing it at rank #8 among India's top actinomycin export destinations globally.
On the import side, key buyers of Indian actinomycin in Sri Lanka include BANK OF CEYLON, THE ESSES PHARMACY(PRIVATE) LIMITED, THE ESSES PHARMACY PRIVATE LIMITED and 3 others. BANK OF CEYLON is the single largest importer with 1 shipments valued at $11.7K USD.
